-
1
-
-
65349135347
-
Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma
-
Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res. 2009; 15: 2905-2912.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 2905-2912
-
-
Li, Y.X.1
Liu, Q.F.2
Fang, H.3
-
2
-
-
65449159015
-
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project
-
Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009; 113: 3931-3937.
-
(2009)
Blood.
, vol.113
, pp. 3931-3937
-
-
Au, W.Y.1
Weisenburger, D.D.2
Intragumtornchai, T.3
-
3
-
-
70649108568
-
Extranodal NK/T-cell lymphoma, nasal type: New staging system and treatment strategies
-
Kim TM, Heo DS,. Extranodal NK/T-cell lymphoma, nasal type: new staging system and treatment strategies. Cancer Sci. 2009; 100: 2242-2248.
-
(2009)
Cancer Sci.
, vol.100
, pp. 2242-2248
-
-
Kim, T.M.1
Heo, D.S.2
-
4
-
-
61349149366
-
Extranodal NK/T-cell lymphoma, nasal type
-
Swerdlow S.H. Campo E. Harris N.L. et al, eds. Lyon, France: IARC
-
Chan JK, Quintanilla-Martinez L, Ferry JA, Peh S-C,. Extranodal NK/T-cell lymphoma, nasal type. In:, Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008: 285-288.
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
, pp. 285-288
-
-
Chan, J.K.1
Quintanilla-Martinez, L.2
Ferry, J.A.3
Peh, S.-C.4
-
5
-
-
0342905409
-
Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment
-
Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol. 2000; 18: 54-63.
-
(2000)
J Clin Oncol.
, vol.18
, pp. 54-63
-
-
Kim, G.E.1
Cho, J.H.2
Yang, W.I.3
-
6
-
-
3042513353
-
Angiocentric T-cell and NK/T-cell lymphomas: Radiotherapeutic viewpoints
-
Koom WS, Chung EJ, Yang WI, et al. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys. 2004; 59: 1127-1137.
-
(2004)
Int J Radiat Oncol Biol Phys.
, vol.59
, pp. 1127-1137
-
-
Koom, W.S.1
Chung, E.J.2
Yang, W.I.3
-
7
-
-
0346724526
-
Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/Tcell or T-cell lymphoma
-
Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/Tcell or T-cell lymphoma. Cancer. 2004; 100: 366-375.
-
(2004)
Cancer.
, vol.100
, pp. 366-375
-
-
Li, C.C.1
Tien, H.F.2
Tang, J.L.3
-
8
-
-
37049021104
-
Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: Elucidating the significance of systemic chemotherapy
-
Guo Y, Lu JJ, Ma X, et al. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Oral Oncol. 2008; 44: 23-30.
-
(2008)
Oral Oncol.
, vol.44
, pp. 23-30
-
-
Guo, Y.1
Lu, J.J.2
Ma, X.3
-
9
-
-
51249101520
-
A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type
-
Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol). 2008; 20: 619-625.
-
(2008)
Clin Oncol (R Coll Radiol).
, vol.20
, pp. 619-625
-
-
Wu, X.1
Li, P.2
Zhao, J.3
-
10
-
-
0035074460
-
CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?
-
Kim WS, Song SY, Ahn YC, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol. 2001; 12: 349-352.
-
(2001)
Ann Oncol.
, vol.12
, pp. 349-352
-
-
Kim, W.S.1
Song, S.Y.2
Ahn, Y.C.3
-
11
-
-
34247899237
-
Combined chemotherapy and external beam radiation for stage IE and IIE natural killer Tcell lymphoma of nasal cavity
-
Wang B, Lu JJ, Ma X, et al. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer Tcell lymphoma of nasal cavity. Leuk Lymphoma. 2007; 48: 396-402.
-
(2007)
Leuk Lymphoma.
, vol.48
, pp. 396-402
-
-
Wang, B.1
Lu, J.J.2
Ma, X.3
-
12
-
-
0345017782
-
Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy: Result of chemotherapy in NK/T-cell lymphoma
-
Kim BS, Kim TY, Kim CW, et al. Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy: result of chemotherapy in NK/T-cell lymphoma. Acta Oncol. 2003; 42: 779-783.
-
(2003)
Acta Oncol.
, vol.42
, pp. 779-783
-
-
Kim, B.S.1
Kim, T.Y.2
Kim, C.W.3
-
13
-
-
33645210475
-
Midline NK/T-cell lymphoma nasal-type: Treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors
-
Zhang Y, Wei Y, Wang X, et al. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Hematol Oncol. 2006; 24: 28-32.
-
(2006)
Hematol Oncol.
, vol.24
, pp. 28-32
-
-
Zhang, Y.1
Wei, Y.2
Wang, X.3
-
14
-
-
53549130011
-
Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
-
Wang B, Li XQ, Ma X, Hong X, Lu H, Guo Y,. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol. 2008; 83: 795-799.
-
(2008)
Am J Hematol.
, vol.83
, pp. 795-799
-
-
Wang, B.1
Li, X.Q.2
Ma, X.3
Hong, X.4
Lu, H.5
Guo, Y.6
-
15
-
-
81755172136
-
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-Cell Tumor Study Group study
-
Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011; 29: 4410-4416.
-
(2011)
J Clin Oncol.
, vol.29
, pp. 4410-4416
-
-
Yamaguchi, M.1
Kwong, Y.L.2
Kim, W.S.3
-
16
-
-
79951483189
-
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
-
Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 2011; 117: 1834-1839.
-
(2011)
Blood.
, vol.117
, pp. 1834-1839
-
-
Jaccard, A.1
Gachard, N.2
Marin, B.3
-
17
-
-
34548173444
-
Rituximab, gemcitabine and oxaliplatin: An effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy
-
El Gnaoui T, Dupuis J, Belhadj K, et al. Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy. Ann Oncol. 2007; 18: 1363-1368.
-
(2007)
Ann Oncol.
, vol.18
, pp. 1363-1368
-
-
El Gnaoui, T.1
Dupuis, J.2
Belhadj, K.3
-
18
-
-
0042449063
-
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
-
Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999; 17: 1244.
-
(1999)
J Clin Oncol.
, vol.17
, pp. 1244
-
-
Cheson, B.D.1
Horning, S.J.2
Coiffier, B.3
-
19
-
-
0032990022
-
Supraadditive effect of 2′,2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines
-
Faivre S, Raymond E, Woynarowski JM, Cvitkovic E,. Supraadditive effect of 2′,2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines. Cancer Chemother Pharmacol. 1999; 44: 117-123.
-
(1999)
Cancer Chemother Pharmacol.
, vol.44
, pp. 117-123
-
-
Faivre, S.1
Raymond, E.2
Woynarowski, J.M.3
Cvitkovic, E.4
-
20
-
-
0035395143
-
Gemcitabine modulation of alkylator therapy: A phase i trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin
-
Millikan RE, Plunkett WK, Smith TL, Williams DL, Logothetis CJ,. Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin. Cancer. 2001; 92: 194-199.
-
(2001)
Cancer.
, vol.92
, pp. 194-199
-
-
Millikan, R.E.1
Plunkett, W.K.2
Smith, T.L.3
Williams, D.L.4
Logothetis, C.J.5
-
21
-
-
64249111652
-
Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma
-
Kim KH, Joo YD, Sohn CH, et al. Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma. Korean J Intern Med. 2009; 24: 37-42.
-
(2009)
Korean J Intern Med.
, vol.24
, pp. 37-42
-
-
Kim, K.H.1
Joo, Y.D.2
Sohn, C.H.3
-
22
-
-
23444451556
-
Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
-
Oki Y, McLaughlin P, Pro B, et al. Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma. Cancer. 2005; 104: 781-787.
-
(2005)
Cancer.
, vol.104
, pp. 781-787
-
-
Oki, Y.1
McLaughlin, P.2
Pro, B.3
-
23
-
-
38049126171
-
GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: A phase II study
-
Lopez A, Gutierrez A, Palacios A, et al. GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study. Eur J Haematol. 2008; 80: 127-132.
-
(2008)
Eur J Haematol.
, vol.80
, pp. 127-132
-
-
Lopez, A.1
Gutierrez, A.2
Palacios, A.3
-
24
-
-
27244449294
-
Selective apoptosis of natural killer-cell tumours by L-asparaginase
-
Ando M, Sugimoto K, Kitoh T, et al. Selective apoptosis of natural killer-cell tumours by L-asparaginase. Br J Haematol. 2005; 130: 860-868.
-
(2005)
Br J Haematol.
, vol.130
, pp. 860-868
-
-
Ando, M.1
Sugimoto, K.2
Kitoh, T.3
-
25
-
-
33747698361
-
Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract
-
Kim SJ, Kim BS, Choi CW, et al. Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract. Leuk Lymphoma. 2006; 47: 1265-1273.
-
(2006)
Leuk Lymphoma.
, vol.47
, pp. 1265-1273
-
-
Kim, S.J.1
Kim, B.S.2
Choi, C.W.3
-
26
-
-
33644835980
-
Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma
-
Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol. 2006; 24: 181-189.
-
(2006)
J Clin Oncol.
, vol.24
, pp. 181-189
-
-
Li, Y.X.1
Yao, B.2
Jin, J.3
-
27
-
-
2342425819
-
Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan
-
You JY, Chi KH, Yang MH, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol. 2004; 15: 618-625.
-
(2004)
Ann Oncol.
, vol.15
, pp. 618-625
-
-
You, J.Y.1
Chi, K.H.2
Yang, M.H.3
-
28
-
-
0036720257
-
Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality
-
Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW,. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002; 54: 182-190.
-
(2002)
Int J Radiat Oncol Biol Phys.
, vol.54
, pp. 182-190
-
-
Cheung, M.M.1
Chan, J.K.2
Lau, W.H.3
Ngan, R.K.4
Foo, W.W.5
-
29
-
-
84862546219
-
Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
-
Jiang M, Zhang H, Jiang Y, et al. Phase 2 trial of "Sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma. Cancer. 2012; 118: 3294-2301.
-
(2012)
Cancer.
, vol.118
, pp. 3294-2301
-
-
Jiang, M.1
Zhang, H.2
Jiang, Y.3
-
30
-
-
33645455419
-
The effect of pre-irradiation dose intense CHOP on anthracycline resistance in localized nasal NK/T-cell lymphoma
-
Lee SH, Ahn YC, Kim WS, Ko YH, Kim K, Park K,. The effect of pre-irradiation dose intense CHOP on anthracycline resistance in localized nasal NK/T-cell lymphoma. Haematologica. 2006; 91: 427-428.
-
(2006)
Haematologica.
, vol.91
, pp. 427-428
-
-
Lee, S.H.1
Ahn, Y.C.2
Kim, W.S.3
Ko, Y.H.4
Kim, K.5
Park, K.6
-
31
-
-
34547444893
-
The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia
-
Zalewska-Szewczyk B, Andrzejewski W, Młynarski W, Jedrychowska-Danska K, Witas H, Bodalski J,. The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2007; 48: 931-936.
-
(2007)
Leuk Lymphoma.
, vol.48
, pp. 931-936
-
-
Zalewska-Szewczyk, B.1
Andrzejewski, W.2
Młynarski, W.3
Jedrychowska-Danska, K.4
Witas, H.5
Bodalski, J.6
-
32
-
-
33947600985
-
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
-
Douer D, Yampolsky H, Cohen LJ, et al. Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. Blood. 2007; 109: 2744-2750.
-
(2007)
Blood.
, vol.109
, pp. 2744-2750
-
-
Douer, D.1
Yampolsky, H.2
Cohen, L.J.3
-
33
-
-
68449086271
-
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: Extranodal natural killer/T-cell lymphoma
-
Kim HS, Kim KH, Kim KH, et al. Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma. Leuk Lymphoma. 2009; 50: 757-763.
-
(2009)
Leuk Lymphoma.
, vol.50
, pp. 757-763
-
-
Kim, H.S.1
Kim, K.H.2
Kim, K.H.3
-
34
-
-
82955217787
-
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
-
Suzuki R, Yamaguchi M, Izutsu K, et al. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type. Blood. 2011; 118: 6018-6022.
-
(2011)
Blood.
, vol.118
, pp. 6018-6022
-
-
Suzuki, R.1
Yamaguchi, M.2
Izutsu, K.3
|